Trading high volume, page-112

"should be easy to provide by someone in the know"

What? You are demanding insider knowledge?

We are supposed to speculate and join the dots. Something you seem to have forgotten.

Or do you mean it's so easy to provide a range of possibilities. No it isn't. That's what we're here to discuss.

I've never seen a comprehensive analysis by you which deals with the upside of MSB in any credible way.

"Quite fundamental questions?"

In this case you have nervous investors rattled by the low shareprice which does not reflect the colossal upside of the company coming in here for guidance and being told, oh, you should have insider information and if you don't,...

Demanding that others provide definitive answers to an open and realistic probability (and we are only ever dealing with probabilities and relative risk) is kind of fascinating. Lucky for electronic files.

The fact is, the company is seeking partnerships, and the recent ann which sets out investing possibilities in Japan is a join the dots situation whether it can result in investment or deals with MSB.

It's something productive discussion in here could actively speculate on if you'd give the discussion some oxygen. But it's continual attacks. The discussion never takes off properly.

Continually claiming the company has an imminent funding crisis has as much credibility as Joe Hockey's claims of Budget Emergency.

It doesn't, and there is plenty of time for results to come in and for partnerships to be arranged. MSB is the pre-eminent stem cell technology company. Sorry some can't see that.